Gaza Death Toll Tops 60,000 Amid Israel's Genocidal War
A ministry statement said that 113 bodies were brought to hospitals in the last 24 hours, while 637 people were injured, bringing the total number of injuries to 145,870 in the Israeli onslaught.
'Many victims are still trapped under the rubble and on the roads as rescuers are unable to reach them,' it added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
an hour ago
- Free Malaysia Today
New 6% service tax won't hurt medical tourism, says health minister
Malaysia recorded RM2.72 billion in revenue from medical tourism last year, marking a 21% increase from 2023. (Bernama pic) PETALING JAYA : Malaysia's medical tourism is unlikely to be impacted by the expansion of the sales and service tax from July 1, according to the health ministry. Its minister Dzulkefly Ahmad said in a written parliamentary reply that the country's medical tourism sector is expected to remain competitively priced in the region, despite the 6% service tax imposed on foreign patients. 'This is because medical costs in Malaysia are still 30% to 40% lower than in neighbouring countries such as Indonesia, Thailand, and Singapore for key treatments including gastroenterology, cardiology, orthopaedics, and oncology,' he said. He was responding to Dr Ahmad Yunus Hairi (PN-Kuala Langat) who asked about the implications of the expanded SST on Malaysia's reputation as the leading medical tourism destination. Yunus pointed out that Malaysia had generated over RM2 billion in revenue and attracted 1.3 million medical tourists from around the world in 2023. In June, the finance ministry announced a 6% service tax on private healthcare, traditional and complementary medicine, and allied health services provided to foreigners. The tax applies to service providers whose total taxable revenue from all services exceeds RM1.5 million over the past 12 months. Dzulkefly said the medical tourism industry continues to show highly positive growth. 'In 2024, the sector's performance has seen even stronger growth, with revenue from health tourism rising to RM2.72 billion, a 21% increase from the previous year. This was driven in part by a 14% increase in arrivals, with 1.59 million health tourists recorded,' he said. He added that Malaysia's health tourism sector offers not only competitive pricing, but is also recognised for its quality of care, clinical effectiveness, and signature Malaysian hospitality.
New Straits Times
3 hours ago
- New Straits Times
NST Leader: Seeking a cure for rising medical costs
Here's a situation no one wants to face — medically or financially. A senior citizen went to a private hospital's emergency unit for a suspected heart attack and was quickly stabilised by the medical staff. Doctors recommended admission to the Intensive Care Unit for two weeks at an astronomical cost of RM250,000. Stunned by the prospect of financial ruin, the patient responded: "If the heart attack doesn't kill me, the hospital bill will." The senior citizen opted to be transferred to a government hospital. The bill for two weeks of treatment came to RM4,000, with another RM36,000 for three angioplasties. The difference in cost highlights the stark choices an uninsured Malaysian must make to receive treatment. This is why the Health Ministry is pushing for Reset, an initiative to address medical inflation by amending the Private Healthcare Facilities and Services Act 1998 to allow for the Diagnosis-Related Group (DRG) payment system. The system will stabilise long-term insurance premiums and improve price transparency. Rising private healthcare costs are often dismissed as a "problem for the rich". They are not. Rising medical costs affect a massive portion of Malaysians, regardless of income level. Medical inflation soared by 15 per cent in 2022, surpassing the regional average of 11 per cent, driven by rising medical technology costs and demographic pressures. The government, to its credit, has not capitulated to private healthcare providers and insurers' assertions that tighter pricing regulations reduce quality and discourage innovation. Instead, it is working on regulatory measures in healthcare financing and private health insurance that balance affordability, sustainability, and quality — while addressing the concerns of private providers and insurers. Instead, it is working on regulatory measures in healthcare financing and private health insurance that balance affordability, sustainability and quality, while addressing the concerns of private providers and insurers. The ministry is reviewing private hospital regulations to curb high, unregulated hospital supply costs, a major driver of claim expenses. Bank Negara has ordered insurers to stagger premium increases to reduce the financial impact on policyholders. To be fair, medical costs are increasing because of rising cost of imported technologies and drugs, increased wages for healthcare professionals, overuse of medical services and the overprescribing of medicines. The poor lifestyles choices of Malaysians don't help, either.
Free Malaysia Today
3 hours ago
- Free Malaysia Today
Health ministry drops case against doctor for dispensing ivermectin
Health ministry officials had seized the antiparasitic drug found in Dr Che Amir Farid Che Isahak's clinic, arguing that it was not a registered product. (Reuters pic) PETALING JAYA : The health ministry has withdrawn a criminal case against a doctor for possessing and dispensing ivermectin. Dr Che Amir Farid Che Isahak said the ministry's decision to drop the case yesterday followed a ruling made by the Federal Court four months ago on a related matter. In March, the apex court unanimously decided to uphold doctors' right to give patients ivermectin. Health ministry officials had raided Che Amir's clinic in Ampang in 2021 during the peak of the Covid-19 pandemic. The raid followed reports that two patients, unconnected to Che Amir, had self-prescribed ivermectin and allegedly suffered acute poisoning and breathing difficulties. Officials seized the antiparasitic drug found in the clinic, arguing that it was not a registered product. They also claimed that the doctor was not legally permitted to sell or dispense the drug. Che Amir was subsequently charged in the magistrates' court with selling and dispensing the drug. When contacted, Che Amir said although the case resulted from the use of ivermectin for Covid-19 patients, the court's decision allows doctors who are proponents of the drug to use it for the prevention or treatment of any other types of diseases or conditions. 'And we can now safely prescribe and dispense ivermectin without fear of being raided anymore.' He also said more diseases had been found to be amenable to treatment with ivermectin, including cancer. However, he said while there had been many preclinical studies, no clinical study had been conducted. 'Ivermectin is emerging as a treatment for many types of cancer. 'For now there are only case reports and testimonies on the treatment of cancer with ivermectin. I hope that clinical trials will be conducted soon.'
